Use access key #2 to skip to page content.
$2.34 -0.14 (-5.65%)
10/7/2008 1:35 PM

Theragenics Corp (TGX)

CAPS Rating:
***

A medical device company serving the cancer treatment and surgical markets. The Company produces, markets and sells TheraSeed(r), its premier palladium-103 prostate cancer treatment device and I-Seed, its iodine-125 based prostate cancer treatment device.

View All Commentary (TGX)

Recs

0

Avatar otrdave (< 20) Submitted: 6/17/08 11:00 AM : Outperform Start Price: $3.46 TGX Score: -8.95

Its a low priced stock, and I believe more small investors can afford it regardless of its value.

Report this Post Replies: 0 | Reply

Featured Broker Partners